These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6090662)

  • 1. 7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-1(2H)-phthalazinone derivatives: synthesis and inhibitory effects on platelet aggregation.
    Sugimoto A; Tanaka H; Eguchi Y; Ito S; Takashima Y; Ishikawa M
    J Med Chem; 1984 Oct; 27(10):1300-5. PubMed ID: 6090662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and inhibitory effect on platelet aggregation of 2-phenyl-1(2H)-phthalazinone derivatives.
    Sugimoto A; Sakamoto K; Fujino Y; Takashima Y; Ishikawa M
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2809-20. PubMed ID: 4085040
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on antiatherosclerotic agents. IX. Synthesis of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626).
    Ishikawa M; Eguchi Y; Sugimoto A
    Chem Pharm Bull (Tokyo); 1980 Sep; 28(9):2770-8. PubMed ID: 7460102
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on antiatherosclerotic agents. VII. Synthesis and structure-activity relationship of 4-hydroxymethyl-1(2H)-phthalazinone derivatives.
    Eguchi Y; Sugimoto A; Ishikawa M
    Chem Pharm Bull (Tokyo); 1980 Sep; 28(9):2763-9. PubMed ID: 7460101
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on antiatherosclerotic agents. Synthesis and inhibitory activities on platelet aggregation of 4-aryl derivatives of 7-ethoxycarbonyl-6,8-dimethyl-1 (2H)-phthalazinone.
    Eguchi Y; Sato Y; Sekizaki S; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2009-15. PubMed ID: 1797422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids: a novel series of potent dual PDE3/PDE4 inhibitory agents.
    Van der Mey M; Bommelé KM; Boss H; Hatzelmann A; Van Slingerland M; Sterk GJ; Timmerman H
    J Med Chem; 2003 May; 46(10):2008-16. PubMed ID: 12723963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on antiatherosclerotic agents. Synthesis of 7-ethoxycarbonyl-4-formyl-6,8-dimethyl-1(2H)-phthalazinone derivatives and related compounds.
    Eguchi Y; Sasaki F; Takashima Y; Nakajima M; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):795-7. PubMed ID: 2070467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of anti-aggregating activity of PGI2 by 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in rabbit platelets in vitro.
    Tanaka K; Harada Y; Iwata M; Katori M
    Prostaglandins; 1980 Aug; 20(2):255-68. PubMed ID: 6997930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
    Demirayak S; Karaburun AC; Beis R
    Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains.
    Meanwell NA; Pearce BC; Roth HR; Smith EC; Wedding DL; Wright JJ; Buchanan JO; Baryla UM; Gamberdella M; Gillespie E
    J Med Chem; 1992 Jul; 35(14):2672-87. PubMed ID: 1321910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation.
    Meanwell NA; Roth HR; Smith EC; Wedding DL; Wright JJ; Fleming JS; Gillespie E
    J Med Chem; 1991 Sep; 34(9):2906-16. PubMed ID: 1654430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel selective PDE4 inhibitors. 1. Synthesis, structure-activity relationships, and molecular modeling of 4-(3,4-dimethoxyphenyl)-2H-phthalazin-1-ones and analogues.
    Van der Mey M; Hatzelmann A; Van der Laan IJ; Sterk GJ; Thibaut U; Timmerman H
    J Med Chem; 2001 Aug; 44(16):2511-22. PubMed ID: 11472205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives.
    Ferrarini PL; Badawneh M; Franconi F; Manera C; Miceli M; Mori C; Saccomanni G
    Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthetic studies of antiatherogenic agents (13). Synthesis of phthalazinol analogues].
    Eguchi Y; Hasegawa Y; Katano E; Komoda Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1987; 21():27-33. PubMed ID: 3506241
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
    Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
    Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG626) on the spinal trigeminal nucleus, ventral posteromedial nucleus, and sensory cortex.
    Azuma H; Takashima Y; Ishikawa M; Sasa M; Fujiwara M
    Jpn J Pharmacol; 1982 Oct; 32(5):767-74. PubMed ID: 6294392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation.
    Tanaka K; Harada Y; Katori M
    Prostaglandins; 1979 Feb; 17(2):235-7. PubMed ID: 375319
    [No Abstract]   [Full Text] [Related]  

  • 20. New 4-substituted phthalazinone derivatives with possible antibacterial activity.
    Kassem EM; Kamel MM; Makhlouf AA; Omar MT
    Pharmazie; 1989 Jan; 44(1):62-3. PubMed ID: 2727034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.